Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSME-IMMUN tick-borne encephalitis vaccine study in Japanese at-risk subjects
jRCTs011180010Completed
- Start
- Apr 2017
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of FSME-IMMUN and tick-borne encephalitis vaccine (inactivated) in tick-borne encephalitis (TBE) (2 arms). Primary endpoint: Frequency of local and systemic adverse reaction of 1st tick-borne encephalitis vaccination. Started Apr 2017; status: completed.
02
Drugs
FSME-IMMUNtick-borne encephalitis vaccine (inactivated)
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on jRCTs011180010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180010.